Coherus Oncology
CHRS
CHRS
110 hedge funds and large institutions have $40.4M invested in Coherus Oncology in 2025 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 33 increasing their positions, 33 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
19% less capital invested
Capital invested by funds: $50M → $40.4M (-$9.58M)
30% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 20
Holders
110
Holding in Top 10
–
Calls
$128K
Puts
$40K
Top Buyers
| 1 | +$686K | |
| 2 | +$289K | |
| 3 | +$177K | |
| 4 |
LPL Financial
San Diego,
California
|
+$117K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$116K |
Top Sellers
| 1 | -$3.79M | |
| 2 | -$1.31M | |
| 3 | -$521K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$502K |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$482K |